Curis
CRIS
#10201
Rank
โ‚น1.56 B
Marketcap
โ‚น121.28
Share price
0.00%
Change (1 day)
-63.74%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น0.17 Billion

According to Curis's latest financial reports the company's total debt is โ‚น0.17 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น0.25 B8.95%
2023-12-31โ‚น0.23 B-28.68%
2022-12-31โ‚น0.32 B-13.07%
2021-12-31โ‚น0.37 B-33.05%
2020-12-31โ‚น0.56 B4633.66%
2019-12-31โ‚น11.83 M-99.52%
2018-12-31โ‚น2.48 B-6.49%
2017-12-31โ‚น2.65 B96.6%
2016-12-31โ‚น1.34 B-15.96%
2015-12-31โ‚น1.60 B-10.46%
2014-12-31โ‚น1.79 B-4.99%
2013-12-31โ‚น1.88 B15.54%
2012-12-31โ‚น1.63 B
2008-12-31N/A-100%
2007-12-31โ‚น15.84 M-81.92%
2006-12-31โ‚น87.67 M-66.59%
2005-12-31โ‚น0.26 B-11.55%
2004-12-31โ‚น0.29 B15.21%
2003-12-31โ‚น0.25 B-56.74%
2002-12-31โ‚น0.59 B16.76%
2001-12-31โ‚น0.50 B78.32%
2000-12-31โ‚น0.28 B384.82%
1999-12-31โ‚น58.98 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Exelixis
EXEL
โ‚น15.85 B 8,866.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น59.57 B 33,594.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น2.59 B 1,365.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.23 B 33.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.466 T 3,091,769.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.585 T 2,593,446.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น0.89 B 406.30%๐Ÿ‡บ๐Ÿ‡ธ USA